Novo Nordisk has increased quarterly net gain by 32%

Danish pharmaceutical company Novo Nordisk increased net profit in the second quarter of 2025 by 32%and income by 13%. The company's operating profit has not justified market expectations in the last quarter, and revenue has exceeded forecasts. Novo Nordisk's net profit in April-June 26.5 billion Danish Krona (4.12 ...